Arousion 2.0: Predictive Arousal Response Management

Publication ID: 24-11857336_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Arousion 2.0: Predictive Arousal Response Management,” Published Technical Disclosure No. 24-11857336_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857336_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,336.

Summary of the Inventive Concept

Arousion 2.0 is an advanced, AI-driven wearable system that detects and responds to arousal activations, predicting and preventing arousal-related disorders while providing personalized recommendations for managing sympathetic nervous system responses.

Background and Problem Solved

The original patent, 'Detection and response to arousal activations', addressed the technical problem of accurately and timely receiving information regarding arousal events. However, it relied on limited sensor data and did not fully leverage machine learning capabilities. Arousion 2.0 builds upon this foundation, overcoming the limitations of the original patent by integrating multi-modal sensor arrays, predictive analytics, and real-time feedback mechanisms to provide a more comprehensive and proactive approach to arousal response management.

Detailed Description of the Inventive Concept

Arousion 2.0 comprises a wearable device equipped with a multi-modal sensor array, capturing electrodermal activity (EDA), heart rate variability, and other physiological signals. The device is connected to a machine learning module that analyzes the signals, incorporating historical data and environmental factors to predict future arousal responses. The system provides real-time, personalized recommendations for managing sympathetic nervous system responses, utilizing haptic feedback and social sharing features to enhance user engagement and support. The predictive analytics module identifies patterns and anomalies in the signals, enabling early detection and prevention of arousal-related disorders.

Novelty and Inventive Step

The new claims introduce a paradigm shift in arousal response management by integrating AI-driven predictive analytics, real-time feedback mechanisms, and social sharing features. The inventive step lies in the combination of these components, which enables proactive, personalized, and community-driven management of sympathetic nervous system responses, distinguishing Arousion 2.0 from the original patent's reactive approach.

Alternative Embodiments and Variations

Alternative embodiments of Arousion 2.0 could include variations in sensor modalities, machine learning algorithms, and feedback mechanisms. For example, incorporating EEG or functional near-infrared spectroscopy (fNIRS) sensors could enhance the system's accuracy, while alternative feedback mechanisms, such as audio or visual cues, could cater to diverse user preferences.

Potential Commercial Applications and Market

Arousion 2.0 has vast commercial potential in the health and wellness, sports performance, and mental health industries. The system could be marketed as a premium wearable device, appealing to individuals seeking advanced stress management and performance optimization tools. Additionally, Arousion 2.0 could be integrated into healthcare systems, providing clinicians with valuable insights for early diagnosis and treatment of arousal-related disorders.

Original Patent Information

Patent NumberUS 11,857,336
TitleDetection and response to arousal activations
Assignee(s)FITBIT, INC.